Wellington Management

Funding rounds backed by Wellington Management.

Export CSV
Funding disclosed in full
$3.1B
Median round
$122.5M
Rounds in calculation
10
10 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Crystalys Therapeutics

Crystalys Therapeutics develops dotinurad, an oral URAT1 inhibitor for treating gout

$130MSeries BBiotechUnited States
10 participantsCormorant Asset ManagementFrazier Life SciencesHBM Healthcare InvestmentsKCap Biotechnology FundNovo HoldingsPivotal bioVenture PartnersSoleus CapitalSR OneTrails Edge Capital PartnersWellington Management
Higharc

Provides AI platform for homebuilding design, estimating and construction

$95MSeries CProptechUnited States
13 participantsFifth WallInsight PartnersLux CapitalMetaPropNC Tweener FundPSP PartnersRXR Arden Digital VenturesSE VenturesSimpson Strong-TieSpark CapitalSuffolk TechnologiesVertex VenturesWellington Management
RQ Bio

Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients

$115MSeries ABiotechUnited Kingdom
8 participantsEQT Life SciencesForbionFrazier Life SciencesLifeArcMonographOxford Science EnterprisesOxford University InnovationWellington Management
Baseten

Builds systems software for AI applications, powering inference and multi-model strategies

$1.5BSeries FAIUnited States
13 participants01AAltimeter CapitalBattery VenturesBlackbirdConvictionD. E. Shaw VenturesDurable Capital PartnersGreylockIVPSands CapitalSpark CapitalVerified CapitalWellington Management
Current

Provides consumer fintech platform helping everyday Americans improve their financial lives

$80MSeries EFintechUnited States
10 participantsAndreessen Horowitz (a16z)AvenirCross RiverFoundation CapitalGeneral CatalystQED InvestorsSapphire VenturesSpringcoast PartnersTiger Global ManagementWellington Management
NinjaOne

Provides a unified IT operations platform for simplifying work

$400MSeries CDeveloper toolsUnited States
10 participantsBDT & MSD PartnersCapitalGHedosophiaICONIQNew Enterprise Associates (NEA)Pinegrove Opportunity PartnersSequoia CapitalTeachers' Venture GrowthWashington Harbour PartnersWellington Management
Quince

Consumer technology platform redefining how premium goods are produced, priced, and d

$500MSeries EEcommerceUnited States
8 participantsBallie GiffordBasis Set VenturesDST GlobalICONIQMarcyPen Capital PartnersNotable CapitalWellington ManagementWndrCo
Encord

Provides AI-native data infrastructure for physical AI systems

$60MSeries CAIUnited States
8 participantsBright Pixel CapitalCrane Venture PartnersCRVHarpoon VenturesIsomer CapitalN47Wellington ManagementY Combinator (YC)
Korsana Biosciences

Develops novel therapies to reduce the burden of neurodegenerative diseases

$175MSeries ABiotechUnited States
8 participantsFairmountForesite CapitalJanus Henderson InvestorsJ.P. Morgan Life Sciences Private CapitalSanofi VenturesTCGXVenrock Healthcare Capital PartnersWellington Management
Caldera Therapeutics

Develops bispecific antibody CLD-423 for inflammatory bowel disease

$37.5MSeries A1BiotechUnited States
5 participantsJanus Henderson InvestorsLAVOmega FundsvenBioWellington Management